Risk Management for Medical Devices
Risk management starts long before submission. For medical device manufacturers, ISO 14971 provides the central framework for identifying hazards, evaluating risks, implementing controls, assessing residual risk, and maintaining risk management throughout the device life cycle.
Many MedTech teams still treat risk management as a document to complete late in development. That creates gaps between design decisions, clinical evidence, usability, software, cybersecurity, biological safety, labelling, post-market surveillance, and technical documentation.
Qmed helps turn risk management into a structured, traceable and practical process — one that supports safer devices, clearer regulatory documentation, and stronger decision-making throughout development and after market entry.
ISO 14971 risk management — more than a file
A strong risk management file should not stand apart from the rest of the device documentation. It should show how hazards have been identified, how foreseeable sequences of events have been considered, how harms and risks have been evaluated, which risk controls have been selected, and how those controls are verified and connected to the wider evidence base.
For devices intended for the European market, risk management also needs to align with MDR or IVDR expectations, technical documentation, clinical evaluation, PMS or PMCF, and quality management processes. When these elements are developed separately, the result can be difficult to defend — even when the individual documents appear complete.
Qmed supports manufacturers in making those connections clear.
What this service covers
Qmed can support medical device risk management activities including:
- ISO 14971 gap assessments and remediation
- risk management plans, risk management reports and risk management files
- hazard identification and risk analysis workshops
- risk control strategy and traceability
- residual risk evaluation and benefit-risk rationale
- alignment between risk management, clinical evaluation, PMS, PMCF, usability, software, cybersecurity, biological evaluation, labelling and technical documentation
- preparation for notified body questions, audit findings or regulatory review
- updates to risk documentation following design changes, post-market signals or new clinical evidence
Our role can be targeted or embedded. Some clients need an independent review of an existing risk file. Others need structured support to build the risk management process from the beginning or remediate documentation that no longer reflects the device, evidence or regulatory strategy.
Typical situations
MedTech innovators often come to Qmed when risk management has become unclear, inconsistent or disconnected from the rest of the development programme.
That may happen when a device is moving toward MDR or IVDR submission, when a notified body has raised questions, when post-market data has changed the risk picture, or when a growing technical file needs stronger traceability between risk controls and supporting evidence.
In other cases, the challenge appears earlier. A startup may need a pragmatic ISO 14971 approach that is robust enough for regulatory expectations without becoming unnecessarily heavy. A more established manufacturer may need external expertise to challenge assumptions, identify gaps and strengthen the risk management logic before review.
How we support this work
Qmed combines regulatory, clinical and quality expertise to help manufacturers make risk management practical, proportionate and defensible.
We listen first to understand the device, intended purpose, users, clinical context, development stage and regulatory pathway. We then help lead the work by identifying where the risk logic needs to be strengthened, which controls are most important, what evidence is needed, and how the risk management file should connect to the broader technical documentation.
The result is clearer documentation, stronger traceability and a risk management process that can be maintained as the device, evidence base and post-market experience evolve.
Talk to Qmed
Tell us where your risk management work stands today — whether you are building an ISO 14971 process, preparing for submission, responding to notified body feedback, or strengthening an existing risk management file.
Qmed can help clarify what needs to be controlled, documented and connected before your next regulatory milestone.